Imported malaria can be expensive to treat, contribute to drug resistance, cause secondary local transmission and threaten the long-term goal of eradication.

Findings, published in the journal The Lancet Infectious Diseases, revealed that countries with the highest average number of imported infections per year over the past decade were France (2,169), UK (1,898) and USA (1,511), followed by Italy (637) and Germany (401).
Infection movement was strongly skewed to a small number of 'high-traffic' routes, with malaria cases originating from West Africa accounting for 56 percent (13,947) of all cases detected in non-endemic countries.
Andrew Tatem, Director of WorldPop and University of Southampton professor of geography, comments: "This is the first worldwide assessment of imported malaria cases in 20 years and mapping this data is hugely valuable in helping us understand how we can mitigate against the effects of the global movements of the disease.
"Imported malaria can be expensive to treat, contribute to drug resistance, sometimes cause secondary local transmission and threaten the long-term goal of eradication. This study forms part of wider efforts to understand patterns of human and malaria parasite movement to help guide elimination strategies."
The research, supported by the Bill and Melinda Gates Foundation, constructed and analysed a database of publically available nationally reported statistics on imported malaria covering more than 50,000 individual cases over ten years.
By mapping this complex network of malaria movements across continents the researchers highlighted that a number of factors, beyond geographic ones, influenced the strength of importation levels. For example, historical, economic, language and cultural ties all play a part - population movements with former colonies had particular influence; such as Nigeria, Ghana and Kenya with the UK, and Mali, Niger and Chad with France.
Source-Eurekalert
MEDINDIA














